Sanger sequencing, often known as the "chain termination method," is a method for determining the nucleotide sequence of DNA. Sanger sequencing performs best for variant screening studies with a small total number of samples. For variant screening studies involving high sample sizes, amplicon sequencing combined with Next Generation Sequencing (NGS) is a more effective and affordable technique.
The Global Sanger Sequencing Market refers to the commercial ecosystem surrounding the use of Sanger sequencing technology, a method for determining the nucleotide sequence of DNA. This technology is essential for various applications, including genetic research, clinical diagnostics, and forensic analysis. Despite the rise of next-generation sequencing (NGS) technologies, Sanger sequencing remains a gold standard due to its accuracy and reliability. The Global Sanger Sequencing Market encompasses the sales, distribution, and development of sequencing reagents, instruments, and associated services.
Global Sanger sequencing market is estimated to be valued at USD 3,149.9 Mn in 2024, and is expected to reach USD 10,130.6 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 18.2% from 2024 to 2031.
Key Players in the Global Sanger Sequencing Market
The Global Sanger Sequencing Market is dominated by several key players who drive the industry through innovation and extensive market reach. Prominent companies include Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Bio-Rad Laboratories, and Beckman Coulter. Thermo Fisher Scientific leads the market with a broad portfolio of sequencing products and services, renowned for their high quality and precision. Agilent Technologies is another significant player, known for its advanced sequencing kits and automated systems that enhance workflow efficiency in the Global Sanger Sequencing Market.
Market Key Trends in the Global Sanger Sequencing Market
Several key trends are shaping the Global Sanger Sequencing Market. One notable trend is the integration of Sanger sequencing with NGS technologies to improve the accuracy and validation of sequencing results. Additionally, there is a growing demand for personalized medicine, which relies heavily on precise genetic information provided by Sanger sequencing. Advances in automation and miniaturization of sequencing instruments are making Sanger sequencing more accessible and user-friendly. These trends are collectively driving innovation and expansion in the Global Sanger Sequencing Market.
Porter Analysis of the Global Sanger Sequencing Market
A Porter analysis provides insights into the competitive dynamics of the Global Sanger Sequencing Market:
Threat of New Entrants: The threat of new entrants is low due to high barriers to entry, including significant capital investment and stringent regulatory requirements. Established companies in the Global Sanger Sequencing Market benefit from economies of scale and brand recognition.
Bargaining Power of Suppliers: The bargaining power of suppliers is moderate. While there are numerous suppliers of raw materials and reagents, the quality and reliability of these supplies are critical, giving established suppliers some leverage in the Global Sanger Sequencing Market.
Bargaining Power of Buyers: The bargaining power of buyers is high. Customers have several options, including alternative sequencing technologies like NGS, which can influence pricing and service offerings in the Global Sanger Sequencing Market.
Threat of Substitutes: The threat of substitutes is moderate. NGS technologies provide faster and more comprehensive sequencing solutions but may lack the accuracy required for certain applications, ensuring continued demand for Sanger sequencing in the Global Sanger Sequencing Market.
Industry Rivalry: Industry rivalry is high due to the presence of several established players and continuous technological advancements. Companies compete on innovation, quality, and cost-effectiveness in the Global Sanger Sequencing Market.
Geographical Regions in the Global Sanger Sequencing Market
The Global Sanger Sequencing Market is segmented into key geographical regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share, driven by extensive research activities, advanced healthcare infrastructure, and significant investments in biotechnology. Europe follows with substantial growth, supported by government funding for genomics research and strong academic institutions. The Asia-Pacific region is experiencing rapid growth due to increasing healthcare expenditures, rising awareness of genetic disorders, and expanding research capabilities. Latin America and the Middle East & Africa are also growing markets, benefiting from improved healthcare access and ongoing investment in research infrastructure. These regions collectively contribute to the dynamics of the Global Sanger Sequencing Market.
Segment Analysis of the Global Sanger Sequencing Market
The Global Sanger Sequencing Market can be segmented based on product type, application, end-user, and region.
By Product Type: The market includes sequencing instruments, reagents and consumables, and software and services. Sequencing instruments form the largest segment due to their essential role in the sequencing process. Reagents and consumables are critical for ongoing operations and drive recurring revenue in the Global Sanger Sequencing Market.
By Application: Applications include diagnostics, research, and forensic analysis. Research applications dominate the market, driven by extensive use in genetic studies and validation of NGS results. Diagnostics is a rapidly growing segment due to the increasing adoption of genetic testing in clinical settings in the Global Sanger Sequencing Market.
By End-User: The market serves academic and research institutes, hospitals and clinics, and pharmaceutical and biotechnology companies. Academic and research institutes represent the largest end-user segment due to their significant role in genomics research. Hospitals and clinics are expanding end-users, reflecting the integration of genetic testing into routine medical practice in the Global Sanger Sequencing Market.
The Global Sanger Sequencing Market is a vital component of the genomics and biotechnology sectors, characterized by its accuracy and reliability in DNA sequencing. Key players like Thermo Fisher Scientific and Agilent Technologies lead the market through innovation and extensive product offerings. Market growth is driven by key trends such as the integration with NGS technologies, advancements in automation, and the increasing demand for personalized medicine. A detailed Porter analysis and segmentation by geographical regions and product types provide a comprehensive understanding of the market dynamics. The Global Sanger Sequencing Market is poised for sustained growth, driven by continuous technological advancements and expanding applications across various sectors.
Get more insights on Global Sanger Sequencing Market
Get more related content on Global Sanger Sequencing Market
Sanger sequencing is also called the chain termination method.
This is particularly an important method that helps in the proper determination of the DNA nucleotide sequence.
The method of sequencing sanger was first developed in the year 1977 by the two-time Nobel Laureate Frederick Sanger and therefore, it is named so.
Whenever the sequencing reaction takes place particularly in the presence of 4 terminated nucleotides, you will get a pool of the DNA fragments which are measured and also separated base by base.View More...
The global Sanger Sequencing Service Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2021-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the sanger sequencing service market include Source BioScience, GenScript Biotech Corporation, Thermo Fisher Scientific, Inc., LGC Science Group Limited, Fasteris SA, CeMIA SA, Quintara Biosciences, GenHunter Corporation, GENEWIZ, Nucleics, SciGenom Labs Pvt.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Sanger Sequencing Service Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/sanger-sequencing-service-market/download-sampleMarket DynamicsThe global market for Sanger sequencing service is growing due to technological advancement, increasing awareness about genetic diseases, rising demand for genotyping services, and increased adoption for personalized medicine.
Expanding the use of pharmacogenomics in drug discovery and development and increased application of Sanger sequencing in animal and plant DNA analysis are other factors leading to growth of this market.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.Additionally, these tools also give inclusive assessment of each application/product segment in the global market of sanger sequencing service.Browse Global Sanger Sequencing Service Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/sanger-sequencing-service-marketMarket SegmentationThe entire sanger sequencing service market has been sub-categorized into application and end-user.
